Cloning and Expression of Human Stem Cell Factor Fused with Thrombopoietin Mimetic Peptide in Escherichia coli
- 31 May 2006
- journal article
- Published by Springer Science and Business Media LLC in Biotechnology Letters
- Vol. 28 (12), 857-862
- https://doi.org/10.1007/s10529-006-9017-7
Abstract
Thrombopoietin (TPO) acts synergistically with stem cell factor (SCF) in hematopoiesis and megakaryopoiesis. In this work, we designed the expression of SCF fused with the monomer or the dimer of TPO mimetic peptide through a flexible peptide linker. The recombinant fusion proteins were produced in E. coli DH5α at up to 25% of total cell proteins. The resultant inclusion bodies were refolded by dilution and purified by ion-exchange chromatography. Subsequent biological activity assays showed that the fusion proteins exhibited higher potency than recombinant human SCF, indicating that they have a potential role for pharmaceutical applications.Keywords
This publication has 11 references indexed in Scilit:
- Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cellsExperimental Hematology, 2005
- Design of Peptoid Analogue Dimers and Measure of Their Affinity for Grb2 SH3 DomainsBiochemistry, 2004
- Chromatographic Methods for the Isolation of, and Refolding of Proteins from, Escherichia coli Inclusion BodiesProtein Expression and Purification, 2002
- Plasminogen activator inhibitor-1 fused with erythropoietin (EPO) mimetic peptide (EMP) enhances the EPO activity of EMPChemical Biology & Drug Design, 2000
- The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesisExperimental Hematology, 2000
- Pharmacokinetics and Hematological Effects of the PEGylated Thrombopoietin Peptide Mimetic GW395058 in Rats and Monkeys After Intravenous or Subcutaneous AdministrationThe International Journal of Cell Cloning, 1999
- Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose CarboplatinBlood, 1999
- Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural CytokineScience, 1997
- Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Published by Wiley